Providers treating patients through direct-to-consumer telehealth services were more likely to prescribe costly, antibiotic resistance medication than in-person doctors, according to the recent findings of a research study.
The RAND Corporation, a Santa Monica, Calif.-based nonprofit organization, compared antibiotic prescribing rates for acute respiratory infection between Teladoc, a direct-to-consumer telemedicine company, and physician offices.
What they found was physicians in both settings were prescribing the same amount of
